Top Markets
Coin of the day
NexgenRx Inc. NexgenRx Inc.

NexgenRx Inc.

NEGXF
Rangering i aksjer #29069
NexgenRx Inc., established in 2003 and based in Toronto, Canada, functions as a... NexgenRx Inc., established in 2003 and based in Toronto, Canada, functions as a third-party administrator for health benefit plans. The company's primary role involves efficiently managing, adjudicating, and processing payments for prescription drug, dental, and various other extended healthcare claims for individuals covered by plans offered by its clients across Canada. Beyond core claims handling, NexgenRx offers Health Care Spending Accounts (HCSAs), providing individuals with dedicated funds for their health or dental expenses. Its service portfolio also encompasses individual and aggregate stop-loss insurance products, emergency medical and travel assistance insurance, and a suite of administrative support functions. These administrative services include the collection and disbursement of premiums for life and long-term disability (LTD) coverage, complemented by advanced reporting tools. To enhance convenience, the company facilitates online claims submission and direct deposit services, along with other specialized ancillary services.
Aksjekurs
$0.325
Sist synkronisert: 2026-08-18
Markedsverdi
$23.11M
Endring (1 dag)
0.00%
Endring (1 år)
62.50%
Land
CA
Handel NexgenRx Inc. (NEGXF)

Kategori

Inntekter for NexgenRx Inc. (NEGXF)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til NexgenRx Inc. er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for NexgenRx Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$450.13B -
US
$415.09B -
US
$201.11B -
US
$282.38B -
US
$145.68B -
US